XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Unaudited Consolidated Statements of Comprehensive Loss - CAD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Condensed Unaudited Consolidated Statements of Comprehensive Loss        
Revenue $ 327,285 $ 200,068 $ 460,774 $ 461,334
Cost of revenue 317,084 134,470 523,001 397,274
Gross profit / (loss) 10,201 65,598 (62,227) 64,060
Operating expenses        
Amortization 592,057 268,932 1,037,244 798,912
General and administrative expenses 2,457,862 2,323,858 6,815,629 5,828,196
Research and development expenses 2,053,366 3,266,756 5,500,030 6,825,816
Sales and marketing expenses 700,232 452,808 1,462,515 1,265,346
Stock-based compensation expense 2,980,352 1,597,779 6,930,434 4,148,806
Share-based payment expense   (39,426)   206,516
Operating expenses 8,783,869 7,870,707 21,745,852 19,073,592
Operating loss (8,773,668) (7,805,109) (21,808,079) (19,009,532)
Other items        
Interest income (93,024) (152,561) (145,687) (94,478)
Changes in fair value of derivative liability 4,846,725 (2,107,474) 7,758,928 3,412,917
Lease modification loss of net investment in sublease (32,486)   (32,486)  
Other Income (27,127) (17,711) (546,322) (71,639)
Foreign exchange (gain)/loss 1,372,059 (186,848) 868,028 479,721
Loss before taxes (14,904,787) (5,340,515) (29,775,512) (22,736,053)
Current income tax expense/(recovery) (1,604)   (528) 2,140
Deferred income tax recovery (11,330) (6,894) (38,605) (56,069)
Net loss (14,891,853) (5,333,621) (29,736,379) (22,682,124)
Other comprehensive income/(loss) 87,781 (14,257) (39,672) 10,330
Comprehensive Loss $ (14,804,072) $ (5,347,878) $ (29,776,051) $ (22,671,794)
Loss per share - basic and fully diluted $ (0.21) $ (0.14) $ (0.58) $ (0.64)
Weighted average number of shares outstanding - basic and fully diluted 69,948,843 36,957,731 51,080,739 35,651,311